# Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

> **NCT00306969** · PHASE1,PHASE2 · COMPLETED · sponsor: **Boston University** · enrollment: 18 (—)

## Conditions studied

- Cutaneous T-Cell Lymphoma

## Interventions

- **DRUG:** bexarotene
- **DEVICE:** photopheresis

## Key facts

- **NCT ID:** NCT00306969
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 18 (—)
- **Last updated:** 2006-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306969, "Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00306969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*